Company Filing History:
Years Active: 2009-2015
Title: Innovations by Hafiz Ahmed
Introduction
Hafiz Ahmed is an accomplished inventor based in Aldie, VA (US). He has made significant contributions to the field of cancer research through his innovative patents. With a total of 3 patents, his work focuses on methods that could potentially revolutionize cancer treatment and diagnosis.
Latest Patents
One of his latest patents is titled "Methods of use for a natural Thomsen-Friedenreich disaccharide compound." This patent discloses a Thomsen-Friedenreich disaccharide-containing glycopeptide purified from cod fish, approximately 100 kDa in size, designated as TFD. The methods described in this patent aim to suppress cancer metastasis. Another notable patent is "Method and assay for determining methylation of GAL3 promoter for early diagnosis of prostate cancer." This patent outlines a non-invasive method and assay for determining prostate cancer and its progression by quantifying levels of promoter methylation of gal-3, optionally in combination with GSTP1 promoter methylation.
Career Highlights
Hafiz Ahmed is affiliated with the University System of Maryland, where he continues to advance his research and innovation in cancer treatment. His work has garnered attention for its potential impact on early diagnosis and treatment options for prostate cancer.
Collaborations
Hafiz collaborates with notable colleagues such as Gerardo Vasta and Prasun Guha, contributing to a dynamic research environment focused on cancer innovations.
Conclusion
Hafiz Ahmed's contributions to cancer research through his patents highlight his commitment to improving diagnosis and treatment options. His innovative methods have the potential to make a significant impact in the medical field.